Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Clauser

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Annales D'Endocrinologie|April 10, 2004
[Genetics in endocrinology]Eric Clauser
Journal De La Societe De Biologie|February 4, 2010
[Structure and functions of the angiotensin II AT1 receptors during evolution]Colette Auzan, Eric Clauser
Molecular and Cellular Endocrinology|December 9, 2008
Angiotensin II AT1 receptor constitutive activation: from molecular mechanisms to pathophysiologyChristophe Petrel, Eric Clauser
Kidney International|July 25, 2008
Role of angiotensin II AT1 receptor activation in cardiovascular diseasesSandrine Billet, Fréderick Aguilar, Camille Baudry, et al.
The Journal of Biological Chemistry|October 8, 2005
Mechanisms of cell-surface rerouting of an endoplasmic reticulum-retained mutant of the vasopressin V1b/V3 receptor by a pharmacological chaperoneJessica Robert, Colette Auzan, Maria Angeles Ventura, et al.
The Journal of Biological Chemistry|November 6, 2004
A novel C-terminal motif is necessary for the export of the vasopressin V1b/V3 receptor to the plasma membraneJessica Robert, Eric Clauser, Patrice Xavier Petit, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 8, 2005
The AT1A receptor "gain-of-function" mutant N111S/delta329 is both constitutively active and hyperreactive to angiotensin IISandrine Billet, Sabine Bardin, Rachida Tacine, et al.
Trends in Endocrinology and Metabolism: TEM|September 10, 2002
Lessons from constitutively active mutants of G protein-coupled receptorsCharles Parnot, Stéphanie Miserey-Lenkei, Sabine Bardin, et al.
The Journal of Biological Chemistry|December 1, 2001
Constitutive internalization of constitutively active agiotensin II AT(1A) receptor mutants is blocked by inverse agonistsStéphanie Miserey-Lenkei, Charles Parnot, Sabine Bardin, et al.
Trends in Endocrinology and Metabolism: TEM|January 26, 2010
The pathophysiology, diagnosis and prognosis of adrenocortical tumors revisited by transcriptome analysesGuillaume Assié, Marine Guillaud-Bataille, Bruno Ragazzon, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Annales D'Endocrinologie|April 10, 2004
[Genetics in endocrinology]Eric Clauser
Journal De La Societe De Biologie|February 4, 2010
[Structure and functions of the angiotensin II AT1 receptors during evolution]Colette Auzan, Eric Clauser
Molecular and Cellular Endocrinology|December 9, 2008
Angiotensin II AT1 receptor constitutive activation: from molecular mechanisms to pathophysiologyChristophe Petrel, Eric Clauser
Kidney International|July 25, 2008
Role of angiotensin II AT1 receptor activation in cardiovascular diseasesSandrine Billet, Fréderick Aguilar, Camille Baudry, et al.
The Journal of Biological Chemistry|October 8, 2005
Mechanisms of cell-surface rerouting of an endoplasmic reticulum-retained mutant of the vasopressin V1b/V3 receptor by a pharmacological chaperoneJessica Robert, Colette Auzan, Maria Angeles Ventura, et al.
The Journal of Biological Chemistry|November 6, 2004
A novel C-terminal motif is necessary for the export of the vasopressin V1b/V3 receptor to the plasma membraneJessica Robert, Eric Clauser, Patrice Xavier Petit, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 8, 2005
The AT1A receptor "gain-of-function" mutant N111S/delta329 is both constitutively active and hyperreactive to angiotensin IISandrine Billet, Sabine Bardin, Rachida Tacine, et al.
Trends in Endocrinology and Metabolism: TEM|September 10, 2002
Lessons from constitutively active mutants of G protein-coupled receptorsCharles Parnot, Stéphanie Miserey-Lenkei, Sabine Bardin, et al.
The Journal of Biological Chemistry|December 1, 2001
Constitutive internalization of constitutively active agiotensin II AT(1A) receptor mutants is blocked by inverse agonistsStéphanie Miserey-Lenkei, Charles Parnot, Sabine Bardin, et al.
Trends in Endocrinology and Metabolism: TEM|January 26, 2010
The pathophysiology, diagnosis and prognosis of adrenocortical tumors revisited by transcriptome analysesGuillaume Assié, Marine Guillaud-Bataille, Bruno Ragazzon, et al.
Pageof 5